Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2025-12-24 @ 3:53 PM
NCT ID:
NCT04574492
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of moderate to severe Rheumatoid Arthritis (RA) according to the investigator.
* Decision to initiate UPA treatment by investigator according to the local product label independent of the participant's participation in the study.
* Has been previously treated with Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) and corresponds to one of the following subgroups:
* Has not been previously exposed to any Biologic Disease-Modifying Antirheumatic Drugs (bDMARD) or Targeted Synthetic Disease-Modifying Antirheumatic Drugs (tsDMARD).
* Has not been previously exposed to tsDMARD and has been previously exposed to \<= 2 bDMARDs.
* Has been previously treated with one tsDMARD and \<=1 bDMARD prior to treatment with that tsDMARD.
Exclusion Criteria:
* Presence of any condition that, in the opinion of the treating physician, prohibits the participant from participating in the study or obscures the assessment of the treatment of RA.
* Diagnosis of rheumatic disease other than RA.
* Diagnosis of juvenile RA.
* Currently participating in an investigational clinical trial.
* Has prior exposure to a bDMARD after exposure to a tsDMARD.
* Has prior exposure to tsDMARD in an investigational clinical trial.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04574492
Study Brief:
Protocol Section:
NCT04574492